CONCENTRIX CORP's ticker is CNXC and the CUSIP is 20602D101. A total of 314 filers reported holding CONCENTRIX CORP in Q4 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $132,445 | -51.2% | 2,093 | -48.9% | 0.00% | -71.4% |
| Q1 2024 | $271,237 | -60.8% | 4,096 | -41.8% | 0.01% | -22.2% |
| Q4 2023 | $691,399 | +99.4% | 7,040 | +62.6% | 0.01% | -18.2% |
| Q3 2023 | $346,796 | +64.2% | 4,329 | +65.5% | 0.01% | +57.1% |
| Q2 2023 | $211,242 | +58254.1% | 2,616 | -12.3% | 0.01% | -41.7% |
| Q1 2023 | $362 | -56.0% | 2,982 | -51.7% | 0.01% | -64.7% |
| Q4 2022 | $823 | -99.9% | 6,176 | -13.0% | 0.03% | +161.5% |
| Q3 2022 | $792,000 | +65.3% | 7,100 | +101.1% | 0.01% | +18.2% |
| Q2 2022 | $479,000 | -23.0% | 3,530 | -5.4% | 0.01% | +83.3% |
| Q1 2022 | $622,000 | +17.8% | 3,733 | +26.4% | 0.01% | -33.3% |
| Q4 2021 | $528,000 | +51.7% | 2,954 | +50.5% | 0.01% | 0.0% |
| Q3 2021 | $348,000 | -29.0% | 1,963 | -35.6% | 0.01% | -30.8% |
| Q2 2021 | $490,000 | -32.2% | 3,049 | -36.9% | 0.01% | +8.3% |
| Q1 2021 | $723,000 | -28.9% | 4,832 | -53.1% | 0.01% | -61.3% |
| Q4 2020 | $1,017,000 | – | 10,303 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Groupe Bruxelles Lambert | 8,773,667 | $555,197,648 | 100.00% |
| Impactive Capital LP | 3,846,370 | $243,398,294 | 9.46% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 623,542 | $39,457,738 | 1.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,271,250 | $80,444,700 | 1.29% |
| Copeland Capital Management, LLC | 985,722 | $62,376,533 | 1.17% |
| Nierenberg Investment Management Company, Inc. | 27,910 | $1,766,145 | 0.99% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 564,732 | $35,736,207 | 0.97% |
| VALLEY WEALTH MANAGERS, INC. | 168,482 | $10,661,541 | 0.85% |
| Bragg Financial Advisors, Inc | 202,698 | $12,826,730 | 0.57% |
| CLARK ESTATES INC/NY | 44,250 | $2,800,140 | 0.53% |